The Patent Office issues a notification of a Notice of Allowance for Amarin's (AMRN) application for a patent that's used in the company's Vascepa product, which is a prescription formulation made up of fish oils and is used to treat high levels of triglycerides. The Patent Office issues NOAs after deciding that a patent can be granted. The FDA approved Vascepa in July. (PR)
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Feb 25, 2015)
at Zacks.com (Feb 23, 2015)
at Benzinga.com (Jan 13, 2015)
at CNBC.com (Feb 28, 2014)
at MarketWatch.com (Jan 21, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs